Comparison of the Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Eradication of Helicobacter pylori Infection, Serum Inflammatory Factors and Total Antioxidant Capacity
- PMID: 25561921
- PMCID: PMC4277628
Comparison of the Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Eradication of Helicobacter pylori Infection, Serum Inflammatory Factors and Total Antioxidant Capacity
Abstract
Helicobacter pylori infection, the most common chronic bacterial infection in the world, and an important cause of gastrointestinal disorders, may be involved in the pathogenesis of some extra-gastrointestinal disturbances, as well as an increase in blood levels of certain inflammatory markers. Anti-bacterial activity against Helicobacter pylori and anti-inflammatory properties of omega-3 fatty acids have been studied in several research studies. The purpose of the present study was the comparison of the effects of Eicosapentaenoic Acid and Docosahexaenoic Acid supplementation on Helicobacter pylori eradication, serum levels of some inflammatory markers and total antioxidant capacity. In a randomized, double-blind, placebo-controlled clinical trial, 97 Helicobacter pylori positive patients (64 patients in the two intervention groups and 33 in the control group), received 2 grams daily of Eicosapentaenoic Acid, Docosahexaenoic Acid or Medium Chain Triglyceride oil as placebo, along with conventional tetra-drug Helicobacter pylori eradication regimen, for 12 weeks. Helicobacter pylori eradication test and measurement of concentration of interleukine-6, interleukine-8, high-sensitivity C-reactive protein and total antioxidant capacity were performed after the intervention. There was no significant difference in eradication rate of the infection, levels of interleukine-6 and total antioxidant capacity among the three groups, while the levels of interleukine-8 and high-sensitivity C-reactive protein were statistically different. Eicosapentaenoic Acid or Docosahexaenoic Acid supplementation had no significant differential impact on the eradication of Helicobacter pylori infection, and serum levels of interleukine-6 and total antioxidant capacity. However, it had a desirable effect on the levels of interleukine-8 and high-sensitivity C-reactive protein in Helicobacter pylori positive patients.
Keywords: Docosahexaenoic acid; Eicosapentaenoic acid; Eradication; Helicobacter pylori; Inflammatory factors.
Similar articles
-
Comparison of the Effects of Eicosapentaenoic Acid With Docosahexaenoic Acid on the Level of Serum Lipoproteins in Helicobacter pylori: A Randomized Clinical Trial.Iran Red Crescent Med J. 2014 Dec 22;17(1):e17652. doi: 10.5812/ircmj.17652. eCollection 2015 Jan. Iran Red Crescent Med J. 2014. PMID: 25763259 Free PMC article.
-
Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.J Physiol Pharmacol. 2001 Aug;52(1 Suppl 1):3-31. J Physiol Pharmacol. 2001. PMID: 11795863 Clinical Trial.
-
Effects of Concurrent Omega-3 and Cranberry Juice Consumption Along with Standard Antibiotic Therapy on the Eradication of Helicobacter pylori, Gastrointestinal Symptoms, Some Serum Inflammatory and Oxidative Stress Markers in Adults with Helicobacter pylori Infection: A Study Protocol for a Randomized Controlled Trial.Infect Drug Resist. 2020 Sep 15;13:3179-3185. doi: 10.2147/IDR.S270057. eCollection 2020. Infect Drug Resist. 2020. PMID: 32982332 Free PMC article.
-
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016. PLoS One. 2016. PMID: 27723762 Free PMC article. Review.
-
The effect of antioxidants on Helicobacter pylori eradication: A systematic review with meta-analysis.Helicobacter. 2018 Dec;23(6):e12535. doi: 10.1111/hel.12535. Epub 2018 Sep 6. Helicobacter. 2018. PMID: 30191635
Cited by
-
Does a High Ratio of Dietary Omega-6/Omega-3 Fatty Acids Increase the Risk of Helicobacter pylori Infection? A Case-Control Study.Clin Nutr Res. 2024 Jul 26;13(3):176-185. doi: 10.7762/cnr.2024.13.3.176. eCollection 2024 Jul. Clin Nutr Res. 2024. PMID: 39165292 Free PMC article.
-
Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis.BMC Nephrol. 2021 May 1;22(1):160. doi: 10.1186/s12882-021-02351-9. BMC Nephrol. 2021. PMID: 33933009 Free PMC article.
-
Omega-3 Fatty Acids Supplementation and Neuroprotection, Inflammation, Fatigue, and Physical Activity in Multiple Sclerosis: A Randomized Controlled Trial.Food Sci Nutr. 2025 Sep 1;13(9):e70884. doi: 10.1002/fsn3.70884. eCollection 2025 Sep. Food Sci Nutr. 2025. PMID: 40905016 Free PMC article.
-
The antibacterial effect of fatty acids on Helicobacter pylori infection.Korean J Intern Med. 2016 Jan;31(1):30-5. doi: 10.3904/kjim.2016.31.1.30. Epub 2015 Dec 28. Korean J Intern Med. 2016. PMID: 26767854 Free PMC article. Review.
References
-
- Arabi MH, Alvani S, Ehteram H. Lipid profile in subjects with helicobacter pylori infection. Iran. J. Path. 2010;5:199–203.
-
- Khadem Ansari MH, Omrani MD, Sayyah B, Khadem Ansari S. Effect of Helicobacter pylori infection on the lipid, lipoproteins, apolipoprotein A-1, lipoprotein (a) and apolipoprotein-B in patients with gastritis. Afr. J. Micro. Res. 2010;4:84–87.
-
- Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. Br. Med. J. 2008;337:746–750. - PubMed
-
- Nouraie M, Latifi-Navid S, Rezvan H, Radmard AR, Maghsudlu M, Zaer-Rezaii H. Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter . 2009;14:40–46. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials